
Ainos, Inc.
AIMDRating Trend
Earnings History
| Report Date | EPS Actual | EPS Est. | Revenue Actual | Revenue Est. |
|---|---|---|---|---|
| Aug 3, 2026 | $-0.62 | — | $152.00 | — |
| May 13, 2026 | $-0.41 | — | $161.00 | — |
| Mar 30, 2026 | $-0.85 | — | $11.1K | — |
| Nov 13, 2025 | $-0.64 | — | $2.2K | — |
| Aug 13, 2025 | $-0.99 | — | $4.7K | — |
| May 12, 2025 | $-1.05 | — | $106.2K | — |
| Mar 7, 2025 | $-1.30 | — | — | — |
| Nov 6, 2024 | $-1.65 | — | — | — |
News
Partner's Written Confirmation Fulfills Payment Conditions; Initial License Fee Payable Within 15 Business Days HOUSTON, TX / ACCESS Newswire / September 30, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it has completed the required data delivery and technology transfer under its VELDONA® license agreement, triggering a $600,000 initial license payment. The licensing partner confirmed completion in writing on September 29.
Preparations underway for a larger-scale second-phase deployment specified in the existing MOU, building on first-phase deployment experience Advanced packaging deployment marks a major step for Ainos' Chemical Intelligence platform, alongside commercial progress in advanced wafer fabrication HOUSTON, TX / ACCESS Newswire / September 29, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it has completed delivery of all 1,400 AI Nose systems to ASE Tec…
Initial license payment tied to near-term contractual delivery; additional payment opportunities may arise during development, before drug approval Partner assumes assigned clinical and regulatory funding and execution, reducing Ainos' independent capital and staffing requirements Ainos retains existing platform ownership and 25% of applicable net sublicensing revenue; potential economic participation extends beyond the $10 million licensing framework HOUSTON, TX / ACCESS Newswire / September 28…
Ainos, Inc. (NASDAQ: AIMD - Get Free Report) was the recipient of a large growth in short interest in September. As of September 15th, there was short interest totaling 55,787 shares, a growth of 172.6% from the August 31st total of 20,463 shares. Currently, 0.8% of the company's shares are short sold. Based on an average
Partner-funded development marks an important milestone for VELDONA, with BioPhoenix funding and advancing clinical and regulatory development for two initial indications Development funding is additional to the framework; Ainos retains core platform ownership, product supply opportunities and contractual participation in downstream commercial revenue HOUSTON, TX / ACCESS Newswire / September 24, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it ha…
Report points to front-end semiconductor orders, a $2.1 million back-end program and continued dataset expansion as key indicators of Ainos' growing commercial scale HOUSTON, TX / ACCESS Newswire / September 16, 2026 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos" or the "Company") today highlighted a new research update from VASRO GmbH that points to strengthening commercial momentum for Ainos' AI Nose platform across semiconductor applications, supported by initial front-end orders, an established…
Initial commercial orders mark progress toward broader commercial adoption and support revenue-generation opportunities beginning in 2H 2026 Proprietary real-world chemical dataset surpasses 1 billion records, strengthening Ainos' Chemical Intelligence foundation HOUSTON, TX / ACCESS Newswire / September 14, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that its second-generation AI Nose platform is advancing into commercial deployment in front-end sem…
New patents cover electronic nose integration with robotics, expanding Ainos' portfolio of 124 patent assets worldwide across chips, sensing architectures, chemical molecules and real-world applications HOUSTON, TX / ACCESS Newswire / September 9, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it has secured three new Japanese patents covering AI Nose technologies and their integration with robotic systems. The newly granted patents cover gas excha…
High-efficiency, on-site nitrogen generation is designed to protect high-value AI infrastructure, reduce oxidation and environmental degradation, and bring greater flexibility and resilience to semiconductor manufacturing HOUSTON, TX / ACCESS Newswire / August 19, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced the global launch of Atmosphere Engine™ , a new platform that extends the Company's capabilities in AI-powered environmental sensing, Chemical In…
Second-generation platform combines upgraded software, firmware, Edge AI and industrial-grade hardware to support reliable 24/7 real-world deployment More than 878 million real-world smell data records strengthen Ainos' Smell Intelligence foundation, with every AI Nose serving as a continuously learning node toward a broader Chemical Intelligence network HOUSTON, TX / ACCESS Newswire / August 17, 2026 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered Chemical…
Dataset expands by approximately 265 million data points since July 21 as continued AI Nose system deployment across semiconductor manufacturing environments accelerates Ainos' Real-World Data Flywheel and Chemical Intelligence development HOUSTON, TX / ACCESS Newswire / August 13, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that its AI Nose platform has surpassed 878 million real-world smell and chemical data points, primarily generated from semicon…
AI Nose and Atmosphere Engine bring a new layer of environmental perception to intelligent machines HOUSTON, TX / ACCESS Newswire / August 12, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it will showcase its Environmental Intelligence solutions for Physical AI at SEMICON Taiwan 2026, taking place September 2-4. Through AI Nose and Atmosphere Engine, Ainos will demonstrate how Environmental Intelligence can give machines a new way to sense, under…
HOUSTON, TX / ACCESS Newswire / August 10, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced VASRO GmbH has published a new report discussing Ainos' progress in scaling its AI Nose platform through semiconductor deployments, real-world data accumulation, and commercialization opportunities into the second half of 2026. VASRO notes that AI Nose has accumulated approximately 613 million industrial Smell ID data records since December 2025, primarily from sem…